Zimmer Biomet Holdings Inc. reported on Thursday a second-quarter loss of $158 million, or 91 cents per diluted common share on net sales of $1.17 billion. That's a $335 million plunge from the $177 million profit reported for the same three months of last year. The recent deal between Zimmer and Biomet caused the company to lose about $600 million in non-recurring, pre-tax expenses.
